Reaction

Bronchial Fistula reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 194 reports · 3 co-occurring drugs

As of the last recalculation, Bronchial Fistula appears in 194 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is ERLOTINIB HYDROCHLORIDE (PRR 90.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Erlotinib Hydrochloride	10	90.3	90.4
Erlotinib	6	68.5	68.6
Pemetrexed Disodium	14	42.4	42.4

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.